Pharmacological management of neuropathic pain

被引:51
|
作者
McCleane, G [1 ]
机构
[1] Rampk Pain Ctr, Lurgan BT66 7JH, North Ireland
关键词
D O I
10.2165/00023210-200317140-00003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In health, the nervous system exists in a balance between inhibitory and excitatory influences. This balance may be upset if neural tissue is damaged or irritated and may give rise to neuropathic pain. Such neuropathic pain does not respond consistently to opioid analgesics or NSAIDs and it may therefore be necessary to utilise other therapeutic agents with known activity on either the excitatory or inhibitory components of the pain pathway. These other agents are traditionally considered with reference to their original uses; we still refer to tricyclic antidepressants (TCAs) and anticonvulsant drugs when a consideration of their modes of action may allow more rational use. For example, carbamazepine is related to the TCAs by virtue of its chemical structure and proposed mode of action and yet is still classified as an anticonvulsant drug. With respect to the opioids, increasing evidence points to an analgesic effect in neuropathic pain, although concerns regarding tolerance and dependence still prevent more widespread use. The anticonvulsants comprise a group of compounds possessing anticonvulsant and analgesic properties, but each possesses differing modes of action and so several members of the class should be tried before a conclusion is reached that they, as a whole, are ineffective. TCAs may also have a role in the treatment of neuropathic pain. As with all drugs, if their use is not associated with pain relief in a defined period of time, their use should be terminated. Topical TCAs may also have a role where the area of neuropathic pain is small. Other options, such as SSRIs, membrane stabilisers, capsaicin, baclofen and clonidine may have potential in treating neuropathic pain. The available evidence regarding the efficacy of currently available agents for the treatment of neuropathic pain is sparse. With the knowledge of achieving analgesia, according to the modes of actions of various agents it is hoped that the treatment of this difficult condition may be more logical and successful.
引用
收藏
页码:1031 / 1043
页数:13
相关论文
共 50 条
  • [1] Pharmacological Management of Neuropathic Pain
    Gary McCleane
    [J]. CNS Drugs, 2003, 17 : 1031 - 1043
  • [2] The pharmacological management of neuropathic pain
    Ko, Youngkwon
    Kim, Yoon Hee
    [J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2012, 55 (06): : 582 - 592
  • [3] Pharmacological management of neuropathic pain
    Bouchenaki, Hichem
    Begou, Melina
    Magya, Laurent
    Hajj, Rodolphe
    Demiot, Claire
    [J]. THERAPIE, 2019, 74 (06): : 633 - 643
  • [4] Recent Advances in the Pharmacological Management of Neuropathic Pain
    Keogh P.
    Mehta V.
    [J]. Current Anesthesiology Reports, 2016, 6 (4) : 327 - 333
  • [5] New evidence on the pharmacological management of neuropathic pain
    Alcantara Montero, A.
    Sanchez Carnerero, C. I.
    [J]. REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2020, 67 (10): : 574 - 576
  • [6] The pathophysiology and pharmacological management of neuropathic pain in veterinary practice
    Suen, Willy
    [J]. AUSTRALIAN VETERINARY PRACTITIONER, 2007, 37 (02): : 59 - +
  • [7] Pharmacological management of chronic pain: I. Fibromyalgia and neuropathic pain
    Sammons, MT
    [J]. PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 2004, 35 (02) : 206 - 210
  • [8] Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis
    Anastasiia D. Shkodina
    Mainak Bardhan
    Hitesh Chopra
    Onyekachi Emmanuel Anyagwa
    Viktoriia A. Pinchuk
    Kateryna V. Hryn
    Anzhelina M. Kryvchun
    Dmytro I. Boiko
    Vinay Suresh
    Amogh Verma
    Mykhailo Yu. Delva
    [J]. CNS Drugs, 2024, 38 : 205 - 224
  • [9] Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis
    Shkodina, Anastasiia D.
    Bardhan, Mainak
    Chopra, Hitesh
    Anyagwa, Onyekachi Emmanuel
    Pinchuk, Viktoriia A.
    Hryn, Kateryna V.
    Kryvchun, Anzhelina M.
    Boiko, Dmytro I.
    Suresh, Vinay
    Verma, Amogh
    Delva, Mykhailo Yu.
    [J]. CNS DRUGS, 2024, 38 (03) : 205 - 224
  • [10] Pharmacological Management of Neuropathic Pain Following Spinal Cord Injury
    Cathrine Baastrup
    Nanna B. Finnerup
    [J]. CNS Drugs, 2008, 22 : 455 - 475